c peptide levels in mody visible serum C-peptide levels outside of the honeymoon phase - C-peptideintype 1 diabetes level of fasting C-peptide measured at the time of diabetes manifestation Understanding C-Peptide Levels in MODY: A Key Diagnostic Indicator

MODYtreatment Maturity-onset diabetes of the young (MODY) is a group of monogenic forms of diabetes characterized by autosomal dominant inheritance. Differentiating MODY from other types of diabetes, particularly type 1 diabetes (T1D) and type 2 diabetes (T2D), is crucial for appropriate management and treatment. A key diagnostic tool in this differentiation is the measurement of C-peptide levels. This article delves into the significance of C-peptide levels in MODY, exploring what these peptide levels indicate about pancreatic function and how they aid in diagnosis.

What is C-Peptide and Why is it Important?

C-peptide is a byproduct of insulin production. When the pancreas produces insulin, it also releases an equal amount of C-peptide. Therefore, measuring C-peptide level is an indirect yet effective way to assess how much insulin a person’s pancreas is producing themselvesHidden MODY—Looking for a Needle in a Haystack. This is particularly valuable in distinguishing between diabetes types where insulin production is significantly impaired (like T1D) and those where it is preserved or even overproduced initially (like T2D and some forms of MODY).

C-Peptide Levels in MODY: A Multifaceted Picture

The interpretation of C-peptide levels in MODY is nuanced and can vary depending on the specific MODY subtype and the stage of the disease. However, several general observations can be made.

In general, individuals with MODY often exhibit C-peptide level remains in the normal range, especially when compared to those with T1D. Studies have shown that C-peptide levels in the MODY group can be significantly higher than those in the T1D group.作者：YN Lee·2021·被引用次数：14—Typically, C-peptide levels are low at the time of DKA andincrease within a few weeks/months. In patients with sufficient C-peptide in comparison to their ... For instance, one study reported median C-peptide levels of 1.78 (1.作者：B Cao·2022·被引用次数：1—When the criteria contained diabetes autoantibody negativity and fastingC-peptide levels≥0.8 ng/mL, only 8.0% of suspectedMODYsubjects ...24–2.88) ng/mL in MODY patients, compared to 0How do I diagnose Maturity Onset Diabetes of the Young in ....86 (0作者：P Johnston—C-peptide level is a measure of how much insulin an individual is producing themselves(Diabetes Genes, 2025). A low level is more suggestive ....34–1.How do I diagnose Maturity Onset Diabetes of the Young in ...22) ng/mL in T1DM and 2.38 (1Maturity-Onset Diabetes of the Young: Rapid Evidence Review.58–4.27) ng/mL in T2DM.This study aimed to detectMODYamong long standing, clinically diagnosed T1DM patients with preservedC-peptide levels. Methods This was a hospital-based ... Another comparison indicated a MODY average of 12025年10月13日—C-peptidetest: This test measures how much insulin your body makes. People withMODYstill make some insulin. Genetic tests: These tests ....14 ng/mL, contrasting with 0.2 ng/mL for T1D and 2.4 ng/mL for T2D.

A critical factor is the level of fasting C-peptide measured at the time of diabetes manifestation. In MODY, this fasting C-peptide often remains within the normal range, indicating that the beta cells in the pancreas are still functioning to some extent.COMPARISON OF C-PEPTIDE LEVELS IN MONOGENIC ... This is a stark contrast to T1D, where the immune system attacks and destroys insulin-producing beta cells, leading to very low or zero C-peptide levels.作者：PC Contreras·2020—Two weeks later, negative antibodies for GAD and islet cell antibodies (ICA) andlow C-peptide leveswere obtained, suggesting a low insuline secretory reserve, ... Very low/zero levels of C-peptide are highly suggestive of T1D and a significantly impaired insulin secretory reserve.

Furthermore, it's noted that in many MODY cases, the C-peptide remains in the normal range even after years of insulin treatment and diabetes diagnosis. Similarly, Fasting C-peptide levels were significantly lower in T1D patients than in those diagnosed with MODY subtypesMaturity-Onset Diabetes of the Young: Rapid Evidence .... The presence of detectable C-peptide in a patient with diabetes, especially in the absence of autoantibodies typically associated with T1D, raises suspicion for MODY作者：J Urbanová·2018·被引用次数：33—In our opinion,level of fasting C-peptide measured at the time of diabetes manifestationis the most beneficial in discriminating MODY from type 1 diabetes if .... Some studies suggest that a fasting C-peptide level of 0.8 ng/mL or greater can be a useful initial indicator when considering MODY. C-peptide levels, normal, low, high – all can occur in diabetes, but their patterns in MODY are distinct.

Distinguishing MODY from Other Diabetes Types Using C-Peptide:

The ability of C-peptide testing to differentiate between diabetes types is invaluable.

* MODY vsMaturity-Onset Diabetes of the Young (MODY): What It Is. Type 1 Diabetes (T1D): As highlighted, C-peptide levels are a primary distinguishing factor. While T1D is characterized by autoimmune destruction of beta cells, leading to minimal or absent insulin production (and thus very low C-peptide), most MODY subtypes retain some level of endogenous insulin production作者：A Juszczak·2016·被引用次数：39—In MODYC-peptide remains in the normal rangeand beta-cell antibodies are negative. The lipid profile is normal. Patients with HNF1B-MODY may .... This often results in normal or near-normal C-peptide levels. The absence of diabetic-specific autoantibodies, in conjunction with detectable C-peptide, strongly supports a MODY diagnosis over T1D.

* MODY vs. Type 2 Diabetes (T2D): The distinction here can be more subtle, as T2D also involves residual insulin production. However, research indicates differences作者：B Cao·2022·被引用次数：1—When the criteria contained diabetes autoantibody negativity and fastingC-peptide levels≥0.8 ng/mL, only 8.0% of suspectedMODYsubjects .... For example, C-peptide concentration differed significantly among populations with T1D, T2D, MODY, and LADA (latent autoimmune diabetes in adults).Maturity-onset diabetes of the young (MODY) - ScienceDirect.com While T2D patients may have higher insulin production initially, often leading to higher C-peptide levels than both MODY and T1D, the underlying genetic cause and typical age of onset differentiate them作者：GM Park·2022·被引用次数：7—...C-peptide level of 1.47 ng/mL. No other abnormal liver or kidney ... This report describes the first such case of MODY type 4, caused by a .... Some studies also suggest that urinary C-peptide levels can have high sensitivity for differentiating MODY from T1D or T2D.

* MODY vs2022年8月30日—C-peptide levels, normal, low, high. First-line treatment, sulfonylurea, insulin, metformin. Symptoms. People living with MODY may experience .... LADA: LADA is a slowly progressing autoimmune form of diabetes that shares some characteristics with both T1D and T2D作者：B Cao·2022·被引用次数：1—When the criteria contained diabetes autoantibody negativity and fastingC-peptide levels≥0.8 ng/mL, only 8.0% of suspectedMODYsubjects .... C-peptide testing is also instrumental in distinguishing LADA. Patients with LADA typically have detectable C-peptide, but levels may be lower than in T2D and can decline over time, often falling within a range that can overlap with MODY, hence the importance of considering other clinical and genetic factors.

Specific Scenarios and Further Insights:

There are unique scenarios where C-peptide levels provide critical clues. For instance, visible serum C-peptide levels outside of the honeymoon phase might be indicative of MODY. The "honeymoon phase" in diabetes refers to a temporary period of improved insulin production after initial diagnosis and treatment.

In specific MODY subtypes, C-peptide levels can offer further insights. For example, some studies have noted that serum C-peptide responses were generally low in MODY patients and more pronounced in obese patients, with heterogeneous Insulin Response Index (IRI) responses.

The interpretation of C-peptide levels is most valuable when considered alongside other clinical information. A patient with a family history of diabetes (a hallmark of MODY), normal glucose levels, and normal C-peptide might have a specific type of MODY like GCK-MODY (glucokinase MODY), where blood glucose levels are typically only slightly higher than normal, generally between 5.作者：R Kant·2022·被引用次数：42—In healthy people, fastingC-peptide levelsrange from 0.9 to 1.8 ng per mL (0.3 to 0.6 nmol per L) and increase to 3 to 9 ng per mL (1 to 3 nmol per L) after ...5-8 mmol/L.

In the context of acute complications like diabetic ketoacidosis (DKA), C-peptide levels can also be informative. Typically, C-peptide levels are low at the time of DKA, but they can increase within a few weeks/months in individuals with residual insulin secretory capacity, a feature more common in MODY than in established T1D.

C-peptide testing is a crucial biochemical parameter in the diagnostic puzzle of diabetes. While a C-peptide level of 1.Another clue is if a patient with MODY has a high level of C-peptide – a substance made in the pancreas – during a period of high blood sugar, usually0.6mg/dL...47 ng/mL might be notable in one individual, its interpretation is always contextual. When assessing C-peptide levels in MODY, it's essential to remember that these individuals still make some insulin, which is reflected in their C-peptide measurementsUtility of Fasting C-Peptide for the Diagnostic Differentiation .... Genetic tests often complement C-peptide results for a definitive diagnosis of MODY.

Conclusion:

The measurement of C-peptide levels is an indispensable tool in the diagnostic armamentarium for differentiating MODY from other forms of diabetes. While normal or near-normal C-peptide levels are commonly observed in many MODY cases, their specific values and trends, when analyzed with clinical history, autoantibody status, and genetic testing, provide critical insights into pancreatic beta-cell function.作者：R Kant·2022·被引用次数：42—In healthy people, fastingC-peptide levelsrange from 0.9 to 1.8 ng per mL (0.3 to 0.6 nmol per L) and increase to 3 to 9 ng per mL (1 to 3 nmol per L) after ... Understanding these peptide levels is paramount for accurate diagnosis, enabling targeted treatment strategies and improving patient outcomes.